Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 21, 2004 - Issue 4
Submit an article Journal homepage
92
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Clinical Response and Adverse Events in Young Patients with Sickle Cell Disease Treated with Hydroxyurea

Antonis Kattamis First Department of Pediatrics, University of Athens School of Medicine, Athens, Greece
,
Evangelia Lagona First Department of Pediatrics, University of Athens School of Medicine, Athens, Greece
,
Irini Orfanou First Department of Pediatrics, University of Athens School of Medicine, Athens, Greece
,
Fotini Psichou First Department of Pediatrics, University of Athens School of Medicine, Athens, Greece
,
Vasilis Ladis First Department of Pediatrics, University of Athens School of Medicine, Athens, Greece
,
Emmanuel Kanavakis Department of Medical Genetics, University of Athens School of Medicine, Athens, Greece
,
Anna Metaxotou-Mavrommati Department of Medical Genetics, University of Athens School of Medicine, Athens, Greece
&
Christos Kattamis First Department of Pediatrics, University of Athens School of Medicine, Athens, Greece
 show all
Pages 335-342 | Published online: 09 Jul 2009

REFERENCES

  • Bridges KR, Barabino GD, Brugnara C, et al. A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood. 1996;88:4701-4710.
  • Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332:1317-1322.
  • Ferster A, Tahriri P, Vermylen C, et al. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood. 2001;98:2878-2879.
  • Kinney TR, Helms RW, O’Branski EE, et al. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood. 1999;94:1550- 1554.
  • Koren A, Segal-Kupershmit D, Zalman L, et al. Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia. Pediatr Hematol Oncol. 1999;16:221-232.
  • Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece. Blood Cells Mol Dis. 2000;26:453-466.
  • de Montalembert M, Belloy M, Bernaudin F, et al. Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease. J Pediatr Hematol Oncol. 1997;19:313-318.
  • Rigano P, Rodgers GP, Renda D, Renda MC, Aquino A, Maggio A. Clinical and hematological re-sponses to hydroxyurea in Sicilian patients with HbS/beta-thalassemia. Hemoglobin. 2001;25:9-17.
  • Wang WC, Wynn LW, Rogers ZR, Scott JP, Lane PA, Ware RE. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. J Pediatr. 2001;139:790-796.
  • Moschovi M, Psychou F, Menegas D, Tsangaris GT, Tzortzatou-Stathopoulou F, Nikolaidou P. Hodgkin’s disease in a child with sickle cell disease treated with hydroxyurea. Pediatr Hematol Oncol. 2001;18:371-376.
  • Ware RE, Eggleston B, Redding-Lallinger R, et al. Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood. 2002;99:10-14.
  • Maier-Redelsperger M, de Montalembert M, Flahault A, et al. Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. Blood. 1998;91:4472-4479.
  • Steinberg MH, Lu ZH, Barton FB, Terrin ML, Charache S, Dover GJ. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood. 1997;89:1078-1088.
  • Charache S, Dover GJ, Moore RD, et al. Hydroxyurea: effect on hemoglobin F production in patients with sickle cell anemia. Blood. 1992;79:2555-2565.
  • Milner PF, Kraus AP, Sebes JI, et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med. 1991;325:1476-1481.
  • de Montalembert M, Davies SC. Is hydroxyurea leukemogenic in children with sickle cell disease Blood. 2001;98:2878-2879.
  • Wilson S. Acute leukemia in a patient with sickle-cell anemia treated with hydroxyurea. Ann Intern Med. 2000;133:925-926.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.